clinical trial to study the effects of Ayurvedic medicine in patients with liver problems

An Open-Label Pilot Study of OLILIV Juice to Assess Efficacy and Safety in Mild to Moderate Hepatic Dysfunctions - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106216

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K759- Inflammatory liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Presence of liver dysfunction symptoms (e.g., abdominal pain, fatigue, loss of appetite, right upper quadrant discomfort). AST and ALT greater than 40 IU per L. AST and ALT ratio greater than 0.8. BARD score equal or greater than 2.

Exclusion criteria

Exclusion criteria: Poorly-controlled diabetes, hypertension or CKD. Radiologic imaging consistent with cirrhosis or portal hypertension. Participants having hypersensitive predisposition or hypersensitive to test medicine. Pregnant woman, lactating woman, and woman of childbearing potential who is planning a pregnancy or is unwilling to use appropriate methods of contraception during the study. Participation in an interventional clinical study or administration of any investigational agents in the previous 30 days.

Design outcomes

Primary

Measure	Time frame
Hepatic function, AST and ALT ratio, BARD score, Fibrosis Risk Score and Lipid profileTimepoint: Baseline, 4 weeks, 8 weeks	—

Secondary

Measure	Time frame
Laboratory safety parameters (FBS, CBC, LFT and kidney function tests)Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactMrs Supriti Choudhury

J. B. Roy State Ayurvedic Medical College and Hospital

srikantapandit@gmail.com09831723650

Outcome results